Follow @ebcapital
Recent articles
Why SmileDirectClub Shares Stumbled 16.3% Today
Consumer complaints against the teeth-aligner company have investors frowning.
Epizyme's Cancer Drug to Get Rapid FDA Review for a New Indication
Tazemetostat is already approved to treat advanced epithelioid sarcoma; the biotech is now pursing an approval for advanced follicular lymphoma.
Why XBiotech Shares Are Tumbling 23.4% Today
The company's offer to buy back shares was overtendered, resulting in a prorated deal.
Why Teva Pharmaceutical Is Rallying 10% Today
The company's latest financial results are sparking investor optimism.
Medtronic Recalls Insulin Pumps Over Safety Risk
Retainer rings on its MiniMed 630G and MiniMed 670G insulin pumps have been breaking, which can lead to a health hazard for users.
Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer Study
Cabozantinib may help delay the need for chemotherapy in advanced patients.
Why Invacare Stock Soared 15.9% Today
Investors are optimistic a turnaround will pay off in 2020.
Twist Biosciences and Agilent Settle Dispute, Avoid Costly Trial
Twist will pay Agilent $22.5 million and receive a license to aspects of its technology.
Why ADMA Biologics Is Tumbling 13.5% Today
The company's secondary stock offering was priced below its prior-day closing price.
The FDA Accepted Revance Therapeutics' Application for Approval Of Its Botox Competitor
The company's frown line treatment moved closer to commercialization today.
Why LivePerson Jumped 10.8% in January
Investors are increasingly optimistic conversational commerce will disrupt how consumers connect to businesses.
Why HubSpot Skyrocketed 14.2% In January
The marketing, sales, and service software company won widespread support from Wall Street analysts last month.
Why Globant S.A. Rallied 15.7% in January
Optimism growth tied to Disney+'s global roll-out helped shares surge higher last month.
European Advisory Group Backs Esperion's Cholesterol Drugs
The committee vote puts bempedoic acid on the path for likely approval by the European Medicines Agency.
Drugmaker Eli Lilly Reports Fourth-Quarter Earnings
The pharmaceutical giant reported top- and bottom-line results that exceeded analysts' estimates.
CVS Announces Plan to Eliminate Co-Pays for Diabetes Drugs
The pharmacy giant is offering health insurers and employers a tool to eliminate out-of-pocket costs for diabetics that won't raise their costs either.
Johnson & Johnson Joins the Hunt for a Coronavirus Vaccine
One of the largest pharmaceutical companies in the world will leverage its antiviral research program to attack the rapidly spreading illness.
FDA Agrees to Review Regeneron's Dupixent for Use by Younger Children
The eczema drug is already approved for patients 12 and older; this proposal would allow it to be prescribed to those as young as 6.
Moderna to Begin Developing a Coronavirus Vaccine
The biotechnology company has been awarded a grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine for the fast-spreading illness.
Pfizer to Market Viagra Through Roman's Telehealth Service
Pfizer's U.S. generic drug subsidiary, Greenstone, is partnering with men's health provider Roman to provide Viagra to patients.